Orchestra BioMed, Inc.

NEW HOPE, PA · Founded 2017 · Medtech · Public

Therapeutic devices and systems for procedure-based medicine

Claim this profile

Follows are private to you and power your alerts

Updated · orchestrabiomed.com

Sector
Medtech
Headquarters
NEW HOPE, PA
Founded
2017
Latest Form D
$9.9M, May 2019
Total capital
$20.9M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$20.9M
3 Form D · last May 2019
90 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

201720182019FEDERAL ↑EQUITY ↓Cumulative $20.9M1st Form D$63K2nd Form D$11M3rd Form D$9.9M
201720182019FEDERAL ↑EQUITY ↓Cumulative $20.9M1st Form D$63K2nd Form D$11M3rd Form D$9.9M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$9.9M
  • Private capital raisedForm D · SEC · 2nd filing$11M
  • Offering registeredForm D · SEC · 1st filing$63K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • C. Evan BallantyneExecutive OfficerNamed in SEC Form D filings
  • Darren R. ShermanExecutive Officer, DirectorNamed in SEC Form D filings
  • David P. HochmanExecutive Officer, DirectorNamed in SEC Form D filings
  • Dennis R. DonohoeExecutive OfficerNamed in SEC Form D filings
  • Eileen R. BaileyExecutive OfficerNamed in SEC Form D filings
  • Eric W. FainDirectorNamed in SEC Form D filings
Show all 15 people
  • Eric R. RoseDirectorNamed in SEC Form D filings
  • Geoffrey W. SmithDirectorNamed in SEC Form D filings
  • Hikmat R. HojeibaneExecutive OfficerNamed in SEC Form D filings
  • Inessa R. WheelerExecutive OfficerNamed in SEC Form D filings
  • Jason R. AryehDirectorNamed in SEC Form D filings
  • Michael R. HarrisonExecutive OfficerNamed in SEC Form D filings
  • William R. BaumbachExecutive OfficerNamed in SEC Form D filings
  • Yuval R. MikaExecutive OfficerNamed in SEC Form D filings
  • Ziv R. BelskyExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Prolaio, Inc.Similar federal contract value in Medtech · null in contracts
  • IceCure Medical Ltd.Similar federal contract value in Medtech · null in contracts
  • ZingboxSimilar federal contract value in Medtech · null in contracts
  • ASC OVERLAKE LLCSimilar federal contract value in Medtech · null in contracts
  • Focused Cryo, IncSimilar federal contract value in Medtech · null in contracts
  • Artelon, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .